SRP5218
EIF2AK4 (192-1024), active, GST tagged human
PRECISIO® Kinase, recombinant, expressed in baculovirus infected Sf9 cells, ≥70% (SDS-PAGE), buffered aqueous glycerol solution
Synonym(s):
GCN2, KIAA1338
Sign Into View Organizational & Contract Pricing
All Photos(2)
Select a Size
Change View
10 μG
$456.00
About This Item
UNSPSC Code:
12352200
NACRES:
NA.32
Recommended Products
recombinant
expressed in baculovirus infected Sf9 cells
product line
PRECISIO® Kinase
assay
≥70% (SDS-PAGE)
form
buffered aqueous glycerol solution
specific activity
11.9-16.1 nmol/min·mg
mol wt
~132 kDa
NCBI accession no.
shipped in
dry ice
storage temp.
−70°C
Gene Information
human ... EIF2AK4(440275)
General description
Eukaryotic translation initiation factor 2-α kinase 4 (EIF2AK4), also known as GCN2 is an enzyme encoded by EIF2AK4 gene in humans. In mouse, EIF2AK4 is widely expressed with prominent expression in liver and brain.[1]
Biochem/physiol Actions
Eukaryotic translation initiation factor 2-α kinase 4 (EIF2AK4) is responsible for phosphorylation of the a subunit of the eukaryotic initiation factor 2 (eIF2α).[1] The EIF2AK4 eIF2-α kinase regulates fatty-acid homeostasis in the liver during deprivation of an essential amino acid. The protein p58IPK inhibits EIF2AK4 activity.[2] EIF2AK4 is linked to pulmonary veno-occlusive disease (PVOD) development and its pathway is associated with diseases such as cancer and Alzheimer′s disease.[3] The protein affects many aspects of cellular physiology in response to a number of stresses such as starvation.[4] Mutation in EIF2AK4 may cause autosomal-recessive pulmonary capillary hemangiomatosis (PCH).[5] EIF2AK4 causes tumor growth and angiogenesis by expression of vascular endothelial growth factor (VEGF).[6]
Physical form
Supplied in 50mM Tris-HCl, pH 7.5, 150mM NaCl, 10mM glutathione, 0.1mM EDTA, 0.25mM DTT, 0.1mM PMSF, 25% glycerol.
Preparation Note
after opening, aliquot into smaller quantities and store at -70 °C. Avoid repeating handling and multiple freeze/thaw cycles
Legal Information
PRECISIO is a registered trademark of Merck KGaA, Darmstadt, Germany
Storage Class
10 - Combustible liquids
wgk_germany
WGK 1
flash_point_f
Not applicable
flash_point_c
Not applicable
Choose from one of the most recent versions:
Certificates of Analysis (COA)
Lot/Batch Number
Don't see the Right Version?
If you require a particular version, you can look up a specific certificate by the Lot or Batch number.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Characterization of a mammalian homolog of the GCN2 eukaryotic initiation factor 2alpha kinase
J J Berlanga
European Journal of Biochemistry (2014)
GCN2, an old dog with new tricks
Beata Grallert and Erik Boye
Biochemical Society Transactions, 41 (2013)
EIF2AK4 mutations cause pulmonary veno-occlusive disease, a recessive form of pulmonary hypertension
Melanie Eyries
Nature Genetics, 46(46) (2013)
EIF2AK4 mutations in pulmonary capillary hemangiomatosis
D Hunter Best
Chest, 145 (2013)
p58IPK is an inhibitor of the eIF2a kinase GCN2 and its localization and expression underpin protein synthesis and ER processing capacity.
Anne Roobol
The Biochemical Society, 465 (2014)
Active Filters
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service
